Pfizer is developing a version of its coronavirus vaccine that can be stored up to six months in “normal refrigeration,” according to the company’s chief executive.

The current Pfizer-BioNTech vaccine, which was the first coronavirus vaccine candidate to be authorized for emergency use on Dec. 11, 2020, must be stored at ultracold temperatures and has a more limited shelf life if kept in normal refrigeration.